<i>α</i>-Lipoic Acid-Plus Ameliorates Endothelial Injury by Inhibiting the Apoptosis Pathway Mediated by Intralysosomal Cathepsins in an <i>In Vivo</i> and <i>In Vitro</i> Endothelial Injury Model

<div>Potential mechanism by which LAP alleviates HUVEC and endothelial damage by inhibiting the mitochondrial apoptosis pathway triggered by lysosomal cathepsins.</div>

Oxidative Medicine and Cellular Longevity

fig10

Figure 10

Figure 10: <i>α</i>-Lipoic Acid-Plus Ameliorates Endothelial Injury by Inhibiting the Apoptosis Pathway Mediated by Intralysosomal Cathepsins in an <i>In Vivo</i> and <i>In Vitro</i> Endothelial Injury Model 

Figure 10 | α-Lipoic Acid-Plus Ameliorates Endothelial Injury by Inhibiting the Apoptosis Pathway Mediated by Intralysosomal Cathepsins in an In Vivo and In Vitro Endothelial Injury Model 